The information on this website is intended to provide scientific information about Alkermes products and areas of therapeutic interest. Information may include data on investigational uses of approved or unapproved drugs for which safety and effectiveness have not been established. There is no guarantee that such uses will receive health authority approval and Alkermes does not recommend or suggest use of its medicines in a manner inconsistent with approved labeling.
This section includes selected Alkermes abstracts, posters or oral presentations, which have been accepted for congress presentations in the last 2 years. The content contained in this section is subject to congress copyright permissions.
Sally Ibrahim, MD1,2; Kiran Maski, MD, MPH3; Anne Marie Morse, DO4; Rakesh Bhattacharjee, MD5; Judith Owens, MD3; Luis E. Ortiz, MD6; Gary Feldman, MD7; Narong Simakajornboon, MD8; Joshua Henderson, BA9; Jennifer Gudeman, PharmD10,a; Brian Abaluck, MD11; Femida H. Gwadry-Sridhar, RPh, PhD9
1University Hospitals Cleveland Medical Center, Cleveland, OH, USA; 2Case Western Reserve University School of Medicine, Cleveland, OH, USA; 3Boston Children’s Hospital, Harvard Medical School, Boston, MA, USA; 4Geisinger Commonwealth School of Medicine, Geisinger Medical Center, Janet Weis Children’s Hospital, Danville, PA, USA; 5University of California, San Diego, San Diego, CA, USA; 6Johns Hopkins Medical Institutions, Johns Hopkins All Children’s Hospital, St. Petersburg, FL, USA; 7Ocean Sleep Medicine, Irvine, CA, USA; 8Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA; 9Pulse Infoframe, Boston, MA, USA; 10Avadel Pharmaceuticals, Chesterfield, MO, USA; 11Alkermes, Inc., Waltham, MA, USA*; aAt the time of the study
